Clinical Trial Update: Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated cardiac outcomes of the Rotigotine Transdermal System in adults with advanced-stage Parkinson's disease, and results were posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine Transdermal System (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2010-02-04